Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries

J Hepatol. 2017 Dec;67(6):1348-1350. doi: 10.1016/j.jhep.2017.06.035. Epub 2017 Aug 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents*
  • Developing Countries
  • England
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C*
  • Hepatitis C, Chronic*
  • Humans
  • Prevalence
  • State Medicine
  • Treatment Outcome

Substances

  • Antiviral Agents